Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting.
about
Progress and problems in understanding and managing primary Epstein-Barr virus infectionsEmerging therapeutic strategies for Epstein-Barr virus+ post-transplant lymphoproliferative disorderBurden of de novo malignancy in the liver transplant recipientEpstein-Barr virus infection and posttransplant lymphoproliferative disorderLymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes25 years of live related renal transplantation in children: The Buenos Aires experienceCD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation.Immunotherapy of human cancers using gene modified T lymphocytes.Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients.Infectious complications of lung transplantation.Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate.Diagnostic testing in Epstein-Barr virus infection.Late hepatic allograft dysfunction.De novo malignancies after liver transplantation: a major cause of late death.Viral infections and pediatric liver transplantation.EBV-associated lymphomas in adultsEpstein-Barr virus-associated lymphomas.Posttransplant viral syndromes in pediatric patients: a review.Role of Epstein-Barr virus DNA load monitoring in prevention and early detection of post-transplant lymphoproliferative disease.Epstein-Barr virus-related lymphoproliferation in children after liver transplant: role of immunity, diagnosis, and management.Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease.Epstein-barr virus vaccines.Post-transplant lymphoproliferative disorder: a review.Expression of EBV encoded viral RNA 1, 2 and anti-inflammatory cytokine (interleukin-10) in FFPE lymphoma specimens: a preliminary study for diagnostic implication in PakistanEpstein-Barr virus (EBV) load and interleukin-10 in EBV-positive and EBV-negative post-transplant lymphoproliferative disorders.Autoimmune haemolytic anaemia associated with Epstein Barr virus infection as a severe late complication after kidney transplantation and successful treatment with rituximab: case report.Posttransplant malignancy.Cellular immunotherapy for viral infection after HSC transplantation.Screening and Monitoring for Infectious Complications When Immunosuppressive Agents Are Studied in the Treatment of Autoimmune DisordersIs there a difference in post-transplant lymphoproliferative disorder in adults after solid organ and haematologic stem cell transplantation? Experience in 41 patients.Monomorphic post-transplant lymphoproliferative disorder of the tongue: case report and review of literature.Post-transplant de novo malignancies in renal transplant recipients: the past and present.Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation.Posttransplant lymphoproliferative disorder: a pictorial review.Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation.Immune surveillance and lymphoid malignancy in immunocompromised host.Cytolytic CD4(+)-T-cell clones reactive to EBNA1 inhibit Epstein-Barr virus-induced B-cell proliferationEBV reactivation as a target of luteolin to repress NPC tumorigenesis.BCL6 expression correlates with monomorphic histology in children with posttransplantation lymphoproliferative disease.Matched-pair analysis: identification of factors with independent influence on the development of PTLD after kidney or liver transplantation.
P2860
Q24597706-2712C3E5-EFD7-4544-A3A3-E82D084DCF2EQ26859114-97AAB5C8-6A96-4B92-B452-C173C20C8147Q26859216-DE23120C-4CB8-4B58-8637-9AC5D9E9395BQ27024229-20F34E88-6EFC-4CE7-B23C-FFB7094A32D8Q28271456-E68D2CB0-2BA7-4085-A800-EE45D813F9E4Q28752049-D02FAEA5-C312-43D2-9789-EF20E4FF1CE3Q33851257-1A8CC51B-7F1E-47ED-9569-2AEA262FCA35Q34188383-F0A9B63B-6CB4-4A86-8BEF-799329210D84Q34271690-6C81712D-0125-4450-8122-4E56D60BCD14Q34330062-B5224C9C-1D8B-42B5-95B7-AB863424E032Q34330092-738FE628-D18F-4D61-9557-D3ADC6CDBFD7Q34401554-9B477E40-C6B3-4858-AE7B-05DE520D3161Q34426400-0AE6E0DE-D27D-417D-96AB-7C255D40AE24Q34426430-8C588A12-CBC2-4FE8-AFD2-457922B34D4BQ34572726-464F3133-04AB-4E37-9840-3A47DDE8D18EQ34636601-A71BE57B-3977-4BCA-92E5-C90DB2ED0FB4Q34651670-66BF4862-46D1-4722-96D4-A4164C8BCA40Q34746773-DF2FD4FD-3A0F-4D78-AEF2-A23E6A1C1124Q34769887-58D19C95-E72D-4C2C-9100-B90FA2419CC4Q34861980-7072101F-7CBF-4D8B-80C4-13BA57CF2B26Q34946254-893D94DD-D38A-4C8B-90FF-10AFD4769A52Q35053650-DD72903C-7208-4D54-A444-01E9BACE21A9Q35079593-DC1EF664-17ED-4815-B4FF-B7F809A401C6Q35168623-6010A800-F792-4909-B4CF-04731F8720F4Q35212272-3C2476EF-969C-46DE-AAFC-61905727E2F8Q35695586-39F56386-2415-4233-AB75-3688E325FFAAQ35923812-B095BB50-7C48-4E50-A309-120081202810Q35998792-6C6E0B03-3850-4D34-B5A2-7C65F5E66CD3Q36009655-BB19E9AE-D85D-4202-8721-DBA2DDE53587Q36295658-AECC5233-BF74-475B-A7F0-4477CD21B9BAQ36439991-ED17E24E-B51D-4178-BA59-74FD4AF52E3FQ36530274-254B92CE-0881-4083-8044-45C7CA24A893Q36556729-6D33E278-FF7D-4CDD-ACE8-F287E41EA341Q36596759-EAAFD56D-D4B7-45DC-B892-6DBDC36C1A21Q36732580-0C715D86-A499-49BE-9253-FAC6CC3624E9Q36831205-B5B3A1B5-4DCD-480A-B0DF-5CD90292E99AQ36890569-7291F622-8181-4E0F-A7BA-87F6CF5C738DQ37109915-8B380060-BBFA-48FC-8F81-BE831E2CD791Q37119576-D1772800-CA4A-4F11-8AF2-516E0CF72047Q37145738-C4BBA84A-A8E4-47A4-BC1A-B48E56BF696B
P2860
Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Epstein-Barr virus-induced pos ...... Consensus Development Meeting.
@ast
Epstein-Barr virus-induced pos ...... Consensus Development Meeting.
@en
type
label
Epstein-Barr virus-induced pos ...... Consensus Development Meeting.
@ast
Epstein-Barr virus-induced pos ...... Consensus Development Meeting.
@en
prefLabel
Epstein-Barr virus-induced pos ...... Consensus Development Meeting.
@ast
Epstein-Barr virus-induced pos ...... Consensus Development Meeting.
@en
P2093
P1433
P1476
Epstein-Barr virus-induced pos ...... Consensus Development Meeting.
@en
P2093
Bromberg JS
Habermann TM
Nalesnik MA
Swinnen JL
Wiesner PH
P304
P356
10.1097/00007890-199911270-00015
P577
1999-11-01T00:00:00Z